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Introduction
Podosomes are dynamic actin-enriched membrane structures 
that represent protrusions of the ventral plasma membrane and 
have an important role in invasive cell motility and ECM deg-
radation (Linder, 2007). After the discovery of podosomes in   
fibroblasts transformed by the Rous sarcoma virus (Chen et al., 
1985),  similar  structures  have  also  been  found  in  several 
types of normal cells, including osteoclasts, macrophages, den-
dritic cells, endothelial cells, and vascular smooth muscle cells 
(Linder and Aepfelbacher, 2003). Many invasive cancer cells 
display structures similar to podosomes, called invadopodia, 
that represent the major sites of ECM degradation in these cells. 
The current convention is to use the term podosome for the 
structures found in normal cells and Src-transformed cells and 
to call the structures found in invasive cancer cells invadopodia 
(Gimona et al., 2008).
Podosomes  are  dot-shaped  structures  with  a  diameter 
of 0.5–1 µm and a height of 0.2–5 µm, composed of a core of   
F-actin and actin regulators, such as cortactin and the Arp2/3 
complex, and surrounded by a ring structure containing integ-
rins, scaffolding proteins, and kinases (Linder and Aepfelbacher, 
2003). They are found either isolated both in macrophages and 
dendritic cells or arranged into superstructures in osteoclasts 
and other types of cells. In Src-transformed fibroblasts, podo-
somes are often organized into large rosette-shaped structures 
with a diameter of 5–20 µm. Such podosome rosettes can also 
be  found  in  osteoclasts  (Destaing  et  al.,  2003),  endothelial 
cells (Tatin et al., 2006), and some highly invasive cancer cells 
(Kocher et al., 2009). In particular, osteoclasts seeded on glass 
develop podosomes that are first grouped into clusters, which   
assemble into small podosome rings (or rosettes) and even-
tually into a large beltlike structure at the cell periphery (Destaing   
et al., 2003). When seeded on bone or a bonelike substrate, 
osteoclasts develop a large and dense F-actin ring, called the 
sealing zone, where osteoclasts secrete protons and proteases to 
dissolve and degrade the mineralized matrix (Luxenburg et al., 
2007). Therefore, podosomes can serve as the structural unit for 
superstructures such as podosome rosettes or belts. However, 
the mechanism of the organization of podosomes into such   
superstructures remains obscure.
Focal adhesion kinase (FAK), a 125-kD nonreceptor tyro-
sine kinase localized in focal adhesions, is known for its pivotal 
role in the control of a variety of cell functions (McLean et al., 
2005). FAK was originally identified as a substrate of Src and 
was subsequently found to be activated upon cell adhesion to 
ECM proteins (Guan and Shalloway, 1992) as well as by some 
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Figure 1.  FAK is crucial for podosome rosette assembly in various types of cells. (A) shRNAs specific to FAK (shFAK; clones #1 and #2), PYK2 (shPYK2), 
or luciferase (shLuc) were stably expressed in v-Src–transformed MEFs. HA-FAK resistant to shFAK was reexpressed into the cells expressing shFAK#1 
(shFAK#1/HA-FAK). An equal amount of whole-cell lysates was analyzed by immunoblotting with the indicated antibodies. (B) The cells were stained for 
F-actin. The percentage of the cells containing podosome rosettes in the total counted cells (n ≥ 300) was determined. (C) The cells were subjected to a 
Matrigel invasion assay. Data were quantified and expressed as a percentage relative to the level of the control. (D) HUVECs and those expressing shRNAs 
were analyzed by immunoblotting. A monoclonal anti-PYK2 (mAb) and a polyclonal anti-PYK2 (pAb) were used to detect PYK2. (E) The cells were treated 
with (+) or without () 100 nM PMA for 3 h and stained for F-actin. Arrows indicate podosome rosettes. The percentage of the cells containing podosome 
rosettes in the total counted cells (n ≥ 300) was determined. (F) shRNAs specific to FAK (clones #1 and #2), PYK2, or luciferase were stably expressed in 
CL1-5 cells. HA-FAK resistant to shFAK was reexpressed into the cells expressing shFAK #1. Whole-cell lysates were analyzed by immunoblotting with the 
indicated antibodies. (G) The cells were stained for F-actin, and the percentage of the cells containing podosome rosettes in the total counted cells (n ≥ 300)   
was determined. (H) Cell lysates from RAW264.7 cells and those expressing shRNAs were analyzed by immunoblotting with the indicated antibodies. 115 FAK is required for podosome rosette assembly • Pan et al.
(I) The cells were treated with 100 ng/ml GST-RANKL for 7 d and stained for F-actin and nuclei. Cells containing more than three nuclei were defined 
as osteoclasts. The percentage of the osteoclasts containing podosome clusters, rings, or belts in the total counted osteoclasts (n ≥ 100) was determined.   
(B, C, E, G, and I) Values (means ± SD) are from three independent experiments. *, P < 0.005.
 
growth factors (Sieg et al., 2000; Chen and Chen, 2006). Y397 is 
the major site of FAK autophosphorylation, which creates a high-
affinity binding site for the Src homology (SH) 2 domain of sev-
eral proteins including the Src family kinases (Schaller et al., 
1994). Activated  Src  phosphorylates  FAK  on  multiple  sites   
including Y576 and Y577, both of which are located in the activa-
tion loop within the kinase domain (Calalb et al., 1995). The 
ensuing phosphorylation of FAK on Y576 and Y577 is required 
for the full enzymatic activity of FAK. Fibroblasts derived from 
FAK-null (FAK
/) mouse embryos are more rounded and poorly 
spread than their wild-type (wt) counterparts (Ilić et al., 1995). 
They show an overabundance of focal adhesions, enriched corti-
cal actin filaments at the cell periphery, and a decreased migration 
rate. It has been shown that an increase in peripheral adhesions 
results from an inhibition of turnover in FAK
/ cells, which   
may be attributed to constitutive activation of RhoA and Rho- 
associated kinase (ROCK; Ren et al., 2000; Chen et al., 2002).
Increased  expression  and  tyrosine  phosphorylation  of 
FAK have been correlated with the progression to an invasive 
cell phenotype (Schlaepfer et al., 2004). Given its close rela-
tionship with integrins, focal adhesion proteins, and actin regu-
lators, it is generally believed that FAK plays an important role 
in podosomes/invadopodia. However, some recent studies do 
not appear to support this assumption (Vitale et al., 2008; Chan 
et al., 2009), claiming that although FAK is important for cell 
invasion, it is not required for the formation of invadopodia in 
cancer cells. In this study, we demonstrate that although FAK 
is dispensable for dot-shaped podosomes, it is required for the 
assembly of podosome rosettes. Additionally, our results show   
that the induction of podosome rosettes by FAK promotes   
matrix degradation and cell invasion, supporting a role of FAK in 
malignant tumor progression. We propose that FAK may regu-
late podosome rosettes through its effect on p130Cas phosphory-
lation, Rho signaling, and vimentin intermediate filaments.
Results
FAK, but not PYK2, is crucial for  
the formation of podosome rosettes  
in fibroblasts, endothelial cells, and  
carcinoma cells
We first examined whether FAK plays a role in the formation 
of podosome rosettes in Src-transformed fibroblasts. Depletion   
of FAK, but not the other FAK family member PYK2, significantly 
suppressed podosome rosette formation and Matrigel invasion in 
Src-transformed mouse embryo fibroblasts (MEFs; Figs. 1 [A–C] 
and S1) and Src-transformed NIH3T3 cells (Fig. S2). In human 
umbilical vein endothelial cells (HUVECs), PYK2 was hardly 
detected (Fig. 1 D). Knockdown of FAK completely suppressed 
PMA-induced formation of podosome rosettes in HUVECs   
(Fig. 1 E). In lung carcinoma CL1-5 cells, depletion of FAK, but 
not PYK2, led to a decreased formation of rosettelike structures 
in the cells (Fig. 1, F and G). These structures are truly podosome 
rosettes because they are exclusively found at the ventral aspect 
of the cell and serve as the sites for the cell to degrade underlying 
matrix proteins (Fig. S2 C). Collectively, our results indicate that 
FAK, but not PYK2, is crucial for podosome rosette formation in 
fibroblasts, endothelial cells, and carcinoma cells.
FAK and PYK2 may regulate different 
patterning of podosomal organization  
in osteoclasts
Mouse RAW264.7 cells can differentiate into osteoclast-like 
cells by receptor activator of NFB ligand (RANKL; Boyle   
et al., 2003). After induction by RANKL, RAW264.7 cells 
became multinucleated, and their podosomes were mainly 
organized into a large beltlike structure at the cell periphery (Fig. 1, 
H and I). However, FAK depletion in RAW264.7 cells impaired 
this process, keeping podosomes as clusters in the cells (Fig. 1 I).   
PYK2 depletion also had an adverse effect on the formation of 
podosome belts in differentiated RAW264.7 cells, which led to 
podosome rings being the major type of podosome structures in 
the cells (Fig. 1, H and I). These results suggest that in osteo-
clasts, FAK may be essential for the cluster-to-ring transition of 
podosomes, whereas PYK2 may be crucial for the ring-to-belt 
transition of podosomes.
FAK is dispensable for dot-shaped 
podosomes but is essential for assembly 
into rosette-shaped structures
To examine the necessity of FAK in the assembly of podosome 
rosettes,  FAK
/  MEFs  and  their  wt  counterparts  (FAK
+/+) 
were used in this study (Fig. 2 A). Before transformation by   
v-Src, both FAK
+/+ and FAK
/ MEFs had almost no podosomes   
(Fig. 2 B). Strikingly, v-Src induced podosome rosettes only in 
FAK
+/+ MEFs but not in FAK
/ MEFs (Fig. 2 B). However, 
v-Src induced small dot-shaped podosomes in both FAK
+/+ and 
FAK
/ MEFs to a similar extent (Fig. 2, B–D). These results 
suggest that although FAK is dispensable for dot-shaped podo-
somes, it is essential for the assembly of podosome rosettes. More-
over, the formation of podosome rosettes in v-Src–transformed 
FAK
+/+ MEFs was correlated with increases in ECM degradation   
(Fig. 2 E) and Matrigel invasion (Fig. 2 F). The increased inva-
siveness of v-Src–transformed FAK
+/+ MEFs was not because of 
an increase in matrix metalloproteinases (MMPs; Fig. 2 G).
Elevated expression of FAK is correlated 
with increases in podosome rosette 
formation, matrix degradation, and invasion
To further examine the necessity of FAK for the assembly of 
podosome  rosettes,  an  inducible  (Tet-Off)  FAK  expression 
system was established in v-Src–transformed FAK
/ MEFs   
(Fig. 3 A). As described in Fig. 2, dot-shaped podosomes were 
already present in v-Src–transformed FAK
/ MEFs before 
FAK induction. Only upon FAK expression were podosome   
rosettes allowed to assemble. The extent of podosome rosette JCB • VOLUME 195 • NUMBER 1 • 2011   116
Figure 2.  FAK is dispensable for the formation of dot-shaped podosomes but is essential for the assembly of podosome rosettes. (A) Whole-cell lysates 
from FAK
+/+ MEFs, FAK
/ MEFs, and those transformed by v-Src were analyzed by immunoblotting with the indicated antibodies. (B) The percentage of 
the cells with dot-shaped podosomes and podosome rosettes in the total counted cells (n ≥ 300) was determined. (C) The cells were stained for F-actin 
and cortactin. Representative high-power images are shown. Arrows indicate podosome rosettes. Arrowheads indicate dot-shaped podosomes. (D) v-Src– 
transformed MEFs were seeded on Alexa Fluor 488–conjugated fibronectin (FN) for 24 h and then stained for F-actin. The z stack images were obtained 
and reconstituted by confocal microscopy. The XY and XZ sections of the boxed areas are shown. Left, dot-shaped podosomes; right, podosome rosettes.   
(E) The cells were seeded on Alexa Fluor 488–conjugated fibronectin for 24 h and then stained for F-actin and nuclei. Arrowheads indicate the areas in 
which fibronectin was degraded by dot-shaped podosomes. Arrows indicate the areas in which fibronectin was degraded by podosome rosettes. The 
areas in which fibronectin had been degraded were measured and expressed as fold relative to the level of FAK
+/+ MEFs. (F) Matrigel invasion assay.   
(B, E, and F) Values (means ± SD) are from three independent experiments. *, P < 0.005. (G) An equal amount of whole-cell lysates was analyzed for 
MMP expression by immunoblotting.117 FAK is required for podosome rosette assembly • Pan et al.
formation was correlated with the expression level of FAK   
(Fig. 3 B). Moreover, the increase in podosome rosettes was 
correlated with increases in ECM degradation (Fig. 3 C) and 
invasion (Fig. 3 D). Together, these results suggest that in-
creased expression of FAK may contribute to v-Src–induced 
cell invasion, at least in part, through its effect on the induc-
tion of podosome rosette assembly.
FAK is localized to podosome rosettes  
and some dot-shaped podosomes
Confocal microscopic analysis revealed that FAK is colocalized 
with  active  Src  at  podosome  rosettes  in  v-Src–transformed 
MEFs (Fig. 4, A and B). Like endogenous FAK, GFP-fused 
FAK (GFP-FAK) was found to localize to podosome rosettes. 
Notably, the COOH domain (aa 687–1,053), but not the NH2 
Figure 3.  Increased expression of FAK is correlated with increases in podosome rosette formation, matrix degradation, and cell invasion. (A) An inducible 
(Tet-Off) expression system for wt FAK expression was established in v-Src–transformed FAK
/ MEFs (Tet FAK wt/v-Src). Three cell clones (#2, #7, and 
#12) were selected and maintained in the medium with (+) tetracycline. The cells were allowed to express FAK upon tetracycline withdrawal (). 24 h after 
tetracycline withdrawal, FAK expression was analyzed by immunoblotting. The expression level of FAK was quantified and expressed as fold relative to 
the level of clone #2. (B) Three FAK-inducible clones and a control clone (tetracycline-controlled transactivator [t-TA]) that encodes t-TA were grown in the 
medium with or without tetracycline for 24 h and were then stained for F-actin. Arrows indicate podosome rosettes. The percentage of the cells containing 
podosome rosettes in the total counted cells (n ≥ 300) was determined. 
#, P < 0.05. (C) The cells were grown in the medium with or without tetracycline 
for 24 h and were plated on Alexa Fluor 488–conjugated fibronectin (FN) for another 24 h. The areas in which fibronectin was degraded were measured 
and expressed as fold relative to the area degraded by clone #2 in the presence of tetracycline. 
#, P < 0.05. (D) The cells were grown in the medium with 
or without tetracycline for 24 h and were then subjected to a Matrigel invasion assay. Data were quantified and expressed as fold relative to the level of 
clone #2 in the presence of tetracycline. (B–D) Values (means ± SD) are from at least three independent experiments. *, P < 0.005.JCB • VOLUME 195 • NUMBER 1 • 2011   118
indicate that although FAK is dispensable for the formation   
of dot-shaped podosomes, it is important for their matrix- 
degrading activity.
The Y397 and catalytic activity of FAK  
are essential for the triggering of 
podosome rosette assembly
To examine whether the autophosphorylation site Y397 and 
catalytic activity of FAK are required for the induction of podo-
some rosettes, an inducible (Tet-Off) expression for Y397F and 
domain (aa 1–391), of FAK was localized to podosome rosettes 
(Fig. 4 C), indicating that the COOH domain of FAK is respon-
sible for its targeting to podosome rosettes.
As described in other types of cells, each podosome has 
an F-actin core surrounded by focal adhesion proteins such   
as vinculin (Fig. 4 D). Notably, FAK was found to associate 
with some, but not all, dot-shaped podosomes (Fig. 4, E and F). 
The dot-shaped podosomes with FAK association were more 
potent than those without FAK association in the degradation   
of ECM proteins (Fig. 4, E and F). Together, these results   
Figure 4.  FAK is localized to podosome rosettes and some dot-shaped podosomes. (A and B) v-Src–transformed FAK
+/+ MEFs were fixed and stained for   
F-actin, FAK, paxillin, and active Src (Src pY416). The z stack images were obtained and reconstituted by confocal microscopy. The XY and XZ sections 
of the boxed areas containing a podosome rosette are shown. (C) GFP, GFP-FAK, GFP-FAK-NH2 (GFP-FAK-N) domain, or GFP-FAK-COOH (GFP-FAK-C) 
domain was transiently expressed in Src-transformed 3T3 cells and then stained for F-actin. Arrows indicate podosome rosettes. Note that the GFP-FAK-NH2 
domain is not localized to podosome rosettes. (D) v-Src–transformed MEFs were stained for F-actin, vinculin, and FAK. The representative image shows that 
FAK and vinculin are localized to dot-shaped podosomes. Arrows indicate dot-shaped podosomes that are enlarged and shown in the insets. (E) v-Src– 
transformed FAK
+/+ MEFs were seeded on Alexa Fluor 488–conjugated fibronectin (FN) for 24 h and then stained for F-actin and FAK. Arrowheads indicate 
dot-shaped podosomes without FAK association. Arrows indicate dot-shaped podosomes with FAK association. Note that dot-shaped podosomes with FAK 
association have higher matrix-degrading activity than those without FAK association. (F) The cells were seeded on labeled fibronectin for 24 h. The mean 
degraded area by a dot-shaped podosome was measured (n = 15). Values (means ± SD) are from three independent experiments. *, P < 0.005.119 FAK is required for podosome rosette assembly • Pan et al.
(transactivator of transcription [TAT]–RhoV14) decreased the 
formation of podosome rosettes in v-Src–transformed MEFs 
(Fig. 7 B). In contrast, membrane-permeable C3 exoenzyme 
(TAT-C3), which specifically ADP ribosylates and inacti-
vates Rho, rescued the defect in the podosome rosette forma-
tion caused by FAK depletion (Fig. 7 B). Thus, FAK may 
promote podosome rosette formation, at least in part, through   
its suppression of Rho activity. Indeed, p190RhoGAP was co-
localized with FAK at podosome rosettes (Fig. 7 C) and was 
important for the formation of podosome rosettes (Fig. 7 D).   
Intriguingly, knockdown of p130Cas increased the Rho activ-
ity  (Fig.  7  E),  suggesting  a  potential  role  of  p130Cas  in   
Rho inhibition.
Moreover, inhibition of ROCK by the inhibitor Y27632 
apparently enhanced the formation of dot-shaped podosomes, 
but not podosome rosettes, in v-Src–transformed FAK
/ MEFs 
(Fig. 8, A and B). In contrast, Y27632 significantly promoted 
the  formation  of  podosome  rosettes  in  v-Src–transformed 
FAK
+/+ MEFs (Fig. 8 A), correlating with increases in matrix 
degradation (Fig. 8 C) and Matrigel invasion (Fig. 8 D). These 
results not only support that hyperactivation of Rho and ROCK 
antagonizes the formation of podosome rosettes but also pro-
vide an example to show that increased numbers of dot-shaped 
podosomes do not spontaneously trigger the assembly of podo-
some rosettes in the absence of FAK.
Podosome rosettes are dynamic structures with a life span 
of minutes to hours. The formation of podosome rosettes can be 
divided into three phases: assembly, maintenance, and disassem-
bly (Fig. 8 E). FAK was found to associate with podosomes in the 
early assembly phase and then throughout the process (Fig. 8 E).   
Interestingly, the disassembly of podosome rosettes is always 
manifested by collapse of the F-actin ring structure toward its 
center before it is completely dissolved (Fig. 8 E). Y27632 signifi-
cantly delayed the disassembly phase (Fig. 8 F), suggesting that 
ROCK may facilitate the disassembly of podosome rosettes.
Microtubule is not necessary for the 
formation of podosome rosettes  
in Src-transformed fibroblasts
Microtubule  acetylation  has  been  suggested  to  be  important 
for the formation of podosome belts in osteoclasts (Destaing 
et al., 2005; Gil-Henn et al., 2007). In particular, in PYK2-null 
osteoclasts, Rho activity was increased, whereas microtubule 
acetylation and stability were reduced (Gil-Henn et al., 2007). 
This raises the possibility that FAK might promote podosome 
rosettes  via  regulation  of  microtubule  acetylation.  However,   
we found that although microtubule acetylation was apparently 
reduced in FAK-null MEFs (Fig. S3 A), it was not affected by 
FAK expression and was not correlated with the formation of 
podosome rosettes in Src-transformed MEFs (Fig. S3, B and C).   
Additionally, we demonstrated that the integrity of microtubules 
is not necessary for podosome rosette formation in Src-transformed 
MEFs (Fig. S3 D). Thus, it is possible that microtubule acety-
lation may only be involved in the ring-to-belt transition of 
podosomal organization in osteoclasts. This could also explain 
why PYK2 is essential for the formation of podosome belts, but 
not podosome rings, in osteoclasts (Fig. 1 I).
Y566F/Y577F mutants was established in v-Src–transformed 
FAK
/ MEFs. Although the expression levels of both mutants 
were threefold higher than wt FAK (Fig. 5 A), they hardly in-
duced podosome rosettes (Fig. 5 B), indicating that the Y397 
and catalytic activity of FAK are required for triggering the   
assembly of podosome rosettes.
Moreover, the FAK C mutant with a deletion (aa 687–
1,053) at its COOH domain was defective in inducing podosome 
rosettes in v-Src–transformed FAK
/ MEFs (Fig. 5 E). In con-
trast, the FAK N mutant with a deletion (aa 1–375) at its NH2 
domain was more potent than wt FAK in inducing podosome   
rosettes (Fig. 5 E). The increased capability of the N mutant to 
induce podosome rosettes could be attributed to its increased 
catalytic activity (Fig. 5 F). We have previously demonstrated 
that substitution of FAK at Tyr194 with Glu leads to FAK activa-
tion (Chen et al., 2011). The Y194E mutant significantly increased 
the formation of podosome rosettes in CL1-5 cells (Fig. 5,   
G  and  H).  However,  this  increase  was  suppressed  by  the  Src- 
specific inhibitor PP2 (Fig. 5 H), indicating that the activity of Src 
is required for FAK to induce the assembly of podosome rosettes.
Interaction of FAK with p130Cas is 
important for podosome rosette formation
To examine the mechanisms of induction of podosome rosettes 
by FAK, FLAG epitope–tagged FAK and its various mutants 
were stably reexpressed in v-Src–transformed FAK
/ MEFs 
(Fig. 6 A), and their ability to induce podosome rosettes in those 
cells was measured (Fig. 6 B). Consistent with the results shown 
in Fig. 5, the Y397F mutant was deficient in inducing podosome 
rosettes in v-Src–transformed FAK
/ MEFs (Fig. 6 B). The 
K454R mutant that is defective in ATP binding and thereby has 
a decreased kinase activity was deficient in inducing podosome 
rosettes (Fig. 6 B). Notably, the P712A/P715A mutant defective 
in p130Cas binding (Cary et al., 1998) had an impaired capabil-
ity to induce podosome rosettes (Fig. 6 B), thus suggesting that 
interaction of FAK with p130Cas may be crucial for podosome 
rosette assembly. Accordingly, the tyrosine phosphorylation of 
p130Cas, but not cortactin and Tks5, was correlated with the 
expression of FAK in Src-transformed MEFs (Fig. 6 C).
The  significance  of  p130Cas  expression  in  podosome   
rosettes was demonstrated by a knockdown approach (Fig. 6,   
D and E). However, the constitutively active Y194E mutant   
of  FAK  hardly  induced  p130Cas  phosphorylation  in  SYF 
(src
/ yes
/ fyn
/) cells (Fig. 6 F), suggesting that FAK may 
not be the kinase directly phosphorylating p130Cas. Instead, 
FAK may function as a docking protein for Src to phosphorylate 
p130Cas. Consistent with this notion, the p130Cas SH3 domain 
that interferes with the interaction between FAK and p130Cas 
(Cary  et  al.,  1998)  partially  suppressed  podosome  rosettes   
in Src-transformed 3T3 cells (Fig. 6 G).
Suppression of Rho signaling by FAK is 
crucial for podosome rosette assembly
FAK has been reported to suppress Rho activity (Ren et al., 
2000; Chen et al., 2002). Indeed, the activity of Rho, but not 
Rac and Cdc42, was inversely correlated with the expres-
sion of FAK (Fig. 7 A). Membrane-permeable active Rho JCB • VOLUME 195 • NUMBER 1 • 2011   120
Figure 5.  The Tyr-397 and catalytic activity of FAK are essential for the triggering of podosome rosette assembly. (A) An inducible (Tet-Off) expression 
system for FAK and its mutants was established in v-Src–transformed FAK
/ MEFs. The cells were maintained in the medium with (+) tetracycline. 24 h 
after tetracycline withdrawal (), the cells were lysed and analyzed by immunoblotting. (B) The cells were grown in the absence of tetracycline for 24 h 
and stained for F-actin. Arrows indicate podosome rosettes. The percentage of the cells containing podosome rosettes in the total counted cells (n ≥ 300) 
was determined. (C) The cells were grown in the presence or absence of tetracycline for 24 h and were then subjected to a matrix degradation assay in the 
presence of tetracycline. Data were quantified and expressed as fold relative to the level of the t-TA clone in the presence of tetracycline. (D) The cells were 
grown in the presence or absence of tetracycline for 24 h and were then subjected to a Matrigel invasion assay. Data were quantified and expressed as 
fold relative to the level of the t-TA clone in the presence of tetracycline. (E) FLAG-FAK or its mutants with deletion at the NH2 domain (N) or the COOH 
domain (C) were stably expressed in v-Src–transformed FAK
/ MEFs. An equal amount of whole-cell lysates was analyzed by immunoblotting with 
the indicated antibodies. The formation of podosome rosettes was quantified and expressed as fold relative to that of the cells expressing FLAG-FAK wt.   121 FAK is required for podosome rosette assembly • Pan et al.
CL1-5 cells (Fig. 9 A), concomitant with decreased formation 
of podosome rosettes (Fig. 9 C). Notably, in the control CL1-5 
cells, the vimentin filaments were enriched at the central re-
gion of the cells but were sparse at the cell periphery and the 
surrounding areas of podosome rosettes (Fig. 9 A). However, 
the enhanced structure of the vimentin filaments by FAK deple-
tion or TAT-RhoV14 addition extended to the cell periphery   
Suppression of vimentin filaments by  
FAK facilitates the assembly of  
podosome rosettes
ROCK has been implicated to phosphorylate and regulate the 
organization of the intermediate filaments (Inada et al., 1999). 
We found that FAK depletion or TAT-RhoV14 addition appar-
ently promoted the organization of the vimentin filaments in 
(F) The Y577 phosphorylation of FLAG-FAK was analyzed by immunoblotting. Data were normalized to the protein level and expressed as fold relative to the level 
of FAK wt. Values are the mean from two independent experiments. (G) Stable expression of T7-FAK and Y194E mutant in CL1-5 cells. (H) The cells were 
treated with or without PP2 at 10 µM for 1 h and stained for F-actin. The formation of podosome rosettes was quantified and expressed as a percentage 
relative to the control cells (neomycin) in the absence of PP2. (B–E and H) Values (means ± SD) are from three independent experiments. *, P < 0.005.
 
Figure 6.  Interaction of FAK with p130Cas is important for podosome rosette formation. (A) Stable expression of FLAG-FAK and its mutants in v-Src– 
transformed FAK
/ MEFs. KD, kinase-dead mutant. (B) The formation of podosome rosettes was quantified and expressed as a percentage relative to the 
cells expressing FLAG-FAK wt. (C) FAK was depleted in v-Src–transformed FAK
+/+ MEFs by shRNA (shFAK). Subsequently, HA-FAK resistant to shFAK was 
stably reexpressed into the FAK-depleted cells (shFAK/HA-FAK). The tyrosine phosphorylation of p130Cas (Cas), cortactin, and Tks5 was analyzed. The 
tyrosine phosphorylation of p130Cas was quantified and expressed as a percentage relative to the level in the cells expressing shLuc. The results shown 
are representative of three experiments. (D) Immunoblotting for the p130Cas expression in v-Src–transformed MEFs and those expressing shRNAs specific 
to p130Cas (shCas) or luciferase (shLuc) as a control. (E) The cells were stained for F-actin, and the percentage of the cells containing podosome rosettes 
in the total counted cells (n ≥ 300) was determined. (F) T7-FAK Y194E or c-SrcY527F was transiently expressed in SYF cells, and the tyrosine phosphoryla-
tion of p130Cas (Cas pY) was analyzed. (G) GFP or GFP-p130Cas SH3 domain (GFP-Cas SH3) was transiently expressed in Src-transformed 3T3 cells. 
The cells were stained for F-actin, and the percentage of the cells containing podosome rosettes in the total counted cells expressing GFP or GFP-Cas SH3   
(n ≥ 100) was determined. (B, E, and G) Values (means ± SD) are from three independent experiments. *, P < 0.005.JCB • VOLUME 195 • NUMBER 1 • 2011   122
Figure 7.  Suppression of Rho signaling by FAK is crucial for podosome rosette assembly. (A) The levels of active (GTP-bound) Rho family proteins includ-
ing RhoA, Rac1, and Cdc42 in the cells were measured. The results shown are representative of three experiments. (B) v-Src–transformed MEFs expressing 
shRNA to luciferase (shLuc) were treated with TAT-RhoV14 at various concentrations for 12 h. v-Src–transformed MEFs expressing shRNA to FAK (shFAK) 
were treated with TAT-C3 at various concentrations for 12 h. The formation of podosome rosettes was measured and expressed as a percentage relative to 
that of control cells expressing shLuc. *, P < 0.005 (compared with the shFAK cells without TAT-C3 treatment); 
#, P < 0.005 (compared with the shLuc cells 
without TAT-RhoV14 treatment). (C) Src-transformed 3T3 cells were stained for F-actin, p190RhoGAP (p190A), and FAK. The z stack images were obtained 
and reconstituted by confocal microscopy. The XY and XZ sections of the boxed area containing a podosome rosette are shown. (D) v-Src–transformed 
MEFs and those expressing shRNAs specific to FAK, p190RhoGAP (shp190A), or luciferase were analyzed for the expression of FAK and p190RhoGAP 
by immunoblotting. The level of active RhoA was measured. The formation of podosome rosettes was measured and expressed as a percentage relative to 
that of the control cells expressing shLuc. *, P < 0.005. (B and D) Values (means ± SD) are from three independent experiments. (E) The effect of p130Cas 
knockdown on Rho activity was analyzed. The level of active RhoA was measured, quantified, and expressed as fold relative to the control cells. The results 
shown are the representative of three experiments.123 FAK is required for podosome rosette assembly • Pan et al.
(Fig. 9 A) and inhibited the formation of podosome rosettes   
(Fig. 9 C). Y27632 was able to reverse the effects of FAK de-
pletion and RhoV14 on vimentin filaments and podosome ro-
settes (Fig. 9, A and C). More importantly, partial depletion of   
vimentin was able to compromise the defect in podosome rosette   
formation caused by FAK depletion or TAT-RhoV14 addition   
(Fig. 9, B and C). Besides, in CL1-5 cells, the effects of FAK 
depletion and RhoV14 on vimentin filaments and podosome 
rosettes were confirmed in Src-transformed MEFs (Fig. S4). 
Together, these results suggest that FAK may facilitate the   
assembly of podosome rosettes through its suppression of Rho/
ROCK signaling and vimentin filaments.
Figure 8.  ROCK facilitates the disassembly of podosome rosettes. (A) v-Src–transformed FAK
/ and FAK
+/+ MEFs were treated with (+) or without () 
the ROCK inhibitor Y27632 (10 µM) for 2 h. The percentage of the cells containing dot-shaped podosomes or podosome rosettes in the total counted cells 
(n ≥ 300) was determined. (B) v-Src–transformed FAK
/ MEFs were treated with or without 10 µM Y27632 for 2 h and stained for F-actin and cortactin. 
Representative high-power images are shown. (C) The cells were seeded on Alexa Fluor 488–conjugated fibronectin (FN) for 24 h and then treated with 
or without Y27632 for another 6 h. The areas in which fibronectin had been degraded were measured. Data are expressed as fold relative to the level 
of v-Src–transformed FAK
/ MEFs in the absence of Y27632. 
#, P < 0.05. (D) The cells were subjected to a Matrigel invasion assay in the presence or 
absence of 10 µM Y27632. Data are expressed as fold relative to the level of v-Src–transformed FAK
/ MEFs in the absence of Y27632. (A, C, and D) Values   
(means ± SD) are from at least three independent experiments. (E) v-Src–transformed FAK
+/+ MEFs stably expressing mCherry-FAK and GFP-actin were 
monitored by time-lapse microscopy. Representative sequential images selected at different time points are shown. (F) v-Src–transformed FAK
+/+ MEFs   
stably expressing mCherry-FAK and GFP-actin were monitored by time-lapse microscopy in the presence or absence of 10 µM Y27632. The duration 
(means ± SD) of the disassembly phase in the total counted podosome rosettes (n = 15) was determined. (A, C, D, and F) *, P < 0.005.JCB • VOLUME 195 • NUMBER 1 • 2011   124
depletion of vimentin significantly increased the assembly of 
podosome rosettes in Src-transformed MEFs, which was re-
versed by reexpression of mCherry fluorescent protein–fused 
vimentin (cherry-VIM; Fig. 10 C). Notably, the S39A and S72A 
mutants were less potent than the S39D and S72D mutants in 
suppressing podosome rosettes (Fig. 10 C), indicating that less 
S39 and S72 of vimentin have been reported to be the 
phosphorylation sites for ROCK (Goto et al., 1998). We found 
that the filament structure of vimentin S39D or S72D mutant 
was more apparent than that of vimentin S39A or S72A mutant 
(Fig. 10 B), suggesting that ROCK-mediated phosphorylation 
of vimentin may facilitate its polymerization. Moreover, partial   
Figure 9.  Suppression of vimentin filaments by FAK facilitates the assembly of podosome rosettes. (A) shRNAs specific to FAK (shFAK) or luciferase as a 
control were stably expressed in CL1-5 cells. The control cells were treated with 1 µg/ml TAT-RhoV14 for 12 h. In some cases, the cells were further treated 
with 10 µM Y27632. The cells were stained for F-actin, vimentin (VIM), and nuclei. The boxed areas from the images are enlarged. For the control cells, 
enlarged images from a podosome rosette (a) and the cell periphery (b) are shown. The fluorescent intensity of vimentin filaments per cell was measured 
(n = 30) and expressed as fold relative to the level of the control cells. (B) The CL1-5 cells expressing shFAK were transfected with duplex siRNA specific to 
vimentin (shFAK/siVIM). After 3 d, CL1-5 cells and those transfected with vimentin siRNA were treated with 1 µg/ml TAT-RhoV14 for 12 h. The expression 
of FAK and vimentin was analyzed by immunoblotting. (C) The cells were stained for F-actin. The formation of podosome rosettes was quantified. Values 
(means ± SD) are from three independent experiments. (A and C) *, P < 0.005; 
#, P < 0.05.125 FAK is required for podosome rosette assembly • Pan et al.
BT549 cells (Seals et al., 2005), melanoma RPMI-7951 cells 
(Seals et al., 2005), pancreatic carcinoma PaCa3 cells (Kocher 
et al., 2009), and lung adenocarcinoma cells such as CL1-5 
cells (this study) and A549 cells (unpublished data). Our re-
sults clearly indicate that podosome rosettes are much more 
potent than dot-shaped podosomes to degrade ECM proteins 
(Figs. 2, 5, and 8). In addition, elevated expression of FAK is 
correlated with increases in podosome rosette formation, ECM 
degradation, and Matrigel invasion (Figs. 3 and 5). Conversely, 
FAK  depletion  is  concomitant  with  decreases  in  podosome 
rosette  formation,  ECM  degradation,  and  Matrigel  invasion 
(Figs. 1, 2, and S2). Therefore, our data strongly suggest a link 
between FAK, podosome rosettes, and tumor invasion, which 
may explain, at least in part, why FAK plays an important role 
in tumor progression to a more malignant phenotype (McLean 
et al., 2005).
In this study, we demonstrated that v-Src induces dot-
shaped podosomes both in FAK
/ MEFs and FAK
+/+ MEFs 
to a similar extent (Fig. 2), thus supporting that FAK is dis-
pensable for dot-shaped podosomes, which is in agreement 
with recent studies describing that FAK is not necessary for 
the formation of invadopodia in breast cancer cells and colon 
cancer cells (Vitale et al., 2008; Chan et al., 2009). In contrast, 
Alexander et al. (2008) reported that FAK is present in inva-
dopodia and is essential for invadopodia activity. In this study, 
we observed that FAK is associated with some, but not all, 
dot-shaped podosomes in Src-transformed MEFs (Fig. 4). Our 
findings could reconcile the discrepancy among previous stud-
ies that argue whether or not FAK is present in invadopodia 
(Alexander et al., 2008; Vitale et al., 2008; Chan et al., 2009). 
More importantly, we demonstrate that the dot-shaped podo-
somes with FAK association are more potent than those with-
out FAK association for ECM degradation (Fig. 4, E and F). 
However, it is not clear whether dot-shaped podosomes with 
or without FAK association represent two different stages dur-
ing the maturation of podosomes or two different subgroups 
of podosomes with different fates.
As the catalytic activity of FAK is important for its func-
tion in promoting podosome rosettes, it is possible that phos-
phorylation of certain FAK-interacting proteins by FAK may 
be important for podosome rosette assembly. In accordance 
with this idea, we found that the tyrosine phosphorylation of 
p130Cas is selectively regulated by FAK in Src-transformed 
MEFs, correlating with the formation of podosome rosettes in 
the cells (Fig. 6 C). In addition, the FAK mutant defective in 
p130Cas binding is less potent than wt FAK to restore podo-
some rosettes in Src-transformed FAK
/ MEFs (Fig. 6 B). 
Together, these results indicate that the interaction between 
FAK and p130Cas is important for the induction and/or main-
tenance of podosome rosettes. In fact, p130Cas and its tyrosine 
phosphorylation have been reported to be essential for the for-
mation of podosome rosettes (Brábek et al., 2005) and invado-
podia (Alexander et al., 2008).
In this study, we demonstrated that FAK promotes the 
formation of podosome rosettes in part through its suppression 
of Rho and ROCK in Src-transformed fibroblasts (Figs. 7 and 8). 
Activation of the Rho–ROCK signaling pathway has been 
polymerization of vimentin is inversely correlated with more 
podosome  rosette  formation.  Moreover,  the  NH2-terminal 
fragment (aa 1–138) of vimentin that functions as a dominant- 
negative mutant (Chang et al., 2009) disrupted vimentin filaments 
(Fig. 10 D) and facilitated the formation of podosome rosettes 
(Fig.  10  E).  Collectively,  our  results  suggest  that  enhanced 
phosphorylation and polymerization of vimentin by ROCK may 
antagonize the assembly of podosome rosettes.
Discussion
Podosomes can self-organize into large rosettelike structures 
in some types of cells. However, the mechanism of how this 
self-assembly is triggered remains largely unknown. In this 
study, we identified FAK as a key molecule necessary for the 
induction of podosome rosette assembly. Our results to sup-
port this conclusion are as follows: first, depletion of FAK sup-
pressed the formation of podosome rosettes in Src-transformed 
fibroblasts, endothelial cells, carcinoma cells, and osteoclasts   
(Figs. 1 and S2). Second, oncogenic Src induced the formation 
of podosome rosettes only in FAK
+/+ MEFs but not in FAK
/ 
MEFs (Fig. 2). Third, dot-shaped podosomes were allowed to 
assemble into podosome rosettes only upon induction of FAK 
expression in Src-transformed FAK
/ MEFs (Figs. 3 and 5). 
Finally, in the absence of FAK, increased numbers of dot-shaped 
podosomes by the ROCK inhibitor Y27632 did not sponta-
neously trigger the assembly of podosome rosettes (Fig. 8).   
All of these results support a critical role for FAK in the   
assembly of podosome rosettes.
The formation of podosome belts is necessary for osteo-
clasts to perform bone resorption (Boyle et al., 2003). PYK2, 
the other member of the FAK family, has been reported to be 
essential for podosome belt formation as well as for bone re-
sorption in osteoclasts (Gil-Henn et al., 2007). In this study,   
we demonstrated that depletion of FAK prevents the cluster-to-ring 
transition of podosomal organization in osteoclasts, whereas 
depletion  of  PYK2  prevents  the  ring-to-belt  transition  of   
podosomal organization in the cells (Fig. 1, H and I). These   
results suggest that FAK and PYK2 may coordinately regulate 
different stages of podosomal organization in osteoclasts. As 
the cluster-to-ring transition of podosomal organization in   
osteoclasts is somewhat analogous to podosome rosette assembly 
in other types of cells, the results derived from osteoclasts also 
support a critical role for FAK in podosome rosette assembly. 
However, what is the role of PYK2 in podosome rosette assem-
bly in cells other than osteoclasts? It is apparent that PYK2   
is not able to compensate the function of FAK for podosome   
rosette assembly in MEFs and CL1-5 cells, both of which express 
high levels of endogenous FAK and PYK2 (Fig. 1). In addition, 
although PYK2 is hardly detected in NIH3T3 fibroblasts and 
HUVECs, podosome rosettes can be formed in both types of 
cells (Figs. 1 and S2). Thus, our data suggest that FAK, but not 
PYK2, is crucial for podosome rosette assembly in fibroblasts, 
endothelial cells, and carcinoma cells.
Podosomes/invadopodia are commonly formed in can-
cer cells, whereas podosome rosettes appear to be assembled 
only in some highly invasive cancer cells such as breast cancer JCB • VOLUME 195 • NUMBER 1 • 2011   126
Figure 10.  Phosphorylation and polymerization of vimentin by ROCK antagonize the formation of podosome rosettes. (A) Vimentin was depleted in 
v-Src–transformed FAK
+/+ MEFs by shRNA (shVIM). Subsequently, mCherry-vimentin (cherry-VIM) or its mutants were stably reexpressed in the vimentin-
depleted cells (shVIM/cherry-VIM). The expression of vimentin was analyzed by immunoblotting. (B) The organization of mCherry-vimentin in the cells was 
visualized under a fluorescent microscope (DM LB; Leica). The boxed areas from the images are enlarged. The yellow dashed lines mark the outlines of 
the cells. (C) The formation of podosome rosettes was measured and expressed as a percentage relative to the control cells. (D) mCherry-vimentin or its 
NH2-terminal fragment (aa 1–138) was transiently expressed in Src-transformed 3T3 cells. The cells were stained for vimentin. (E) The percentage of the 
cells containing podosome rosettes in the total counted cells expressing mCherry proteins (n ≥ 100) was determined. (C and E) Values (means ± SD) are 
from three independent experiments. *, P < 0.005; 
#, P < 0.05. (F) A diagram illustrating that FAK may facilitate the assembly of podosome rosettes by 
promotion of p130Cas phosphorylation and suppression of the Rho-ROCK–vimentin pathway.127 FAK is required for podosome rosette assembly • Pan et al.
were  purchased  from  Sigma-Aldrich.  Polyclonal  anti-MMP9  antibody, 
monoclonal anti-MMP2, and antivimentin (for immunoblotting) antibodies 
and collagen were purchased from Millipore. Polyclonal anti-PYK2 anti-
body was purchased from Cell Signaling Technology. Polyclonal anti–FAK 
pY577 and –Src pY416 antibodies were purchased from Invitrogen. The 
mouse ascites containing the monoclonal anti-Src (peptide 2–17) produced 
by hybridoma (CRL-2651) were prepared in our laboratory. Ni-nitrilotriacetic 
acid agarose beads and glutathione Sepharose 4B beads were pur-
chased from GE Healthcare. Fibronectin, PMA, puromycin, hygromycin-B, 
and  Y27632  were  purchased  from  EMD.  Lipofectamine  and  Oligo-
fectamine  were  purchased  from  Invitrogen.  FBS  was  purchased  from 
Thermo Fisher Scientific.
Plasmids
The plasmid pGEX-RANKL was provided by B. Lee (Ohio State University, 
Columbus, OH). The plasmid pKH3-FAK encoding HA-FAK was provided 
by J.L. Guan (University of Michigan, Ann Arbor, MI). The plasmids pEGFP-
FAK and pEGFP-FAK-COOH domain were provided by D. Ilić (University 
of California, San Francisco, San Francisco, CA). The plasmids pTAT-
His-TAT-RhoV14  and  pTAT-His-TAT-C3  were  provided  by  Z.F.  Chang 
(National Yang-Ming University, Taipei, Taiwan). The plasmid pBabe- 
Hygro-p130Cas was provided by G.S. Goldberg (Stony Brook Univer-
sity, Stony Brook, NY). The plasmid pEGFP-N1-vimentin was provided by   
D. Lev (University of Texas M.D. Anderson Cancer Center, Houston, TX). The 
following plasmids were constructed in our laboratory: pEGFP-FAK-NH2 
domain (aa 1–391); pmCherry-FAK; pKH3-FAK nt C1281A/A1284G 
(small  hairpin  RNA  [shRNA]–resistant  mutant);  pLKO-AS2.puro-FLAG-
FAK series including wt, Y397F, K454R, P712A/715A, P878A.881A, 
Y925F, N (deletion of aa 1–374), and C (deletion of aa 687–1,053); 
pEGFP-C2-p130Cas  SH3  (aa  1–113);  and  pmCherry-vimentin  series   
including  wt,  S39A,  S39D,  S72A,  S72D,  and  N-terminal  fragment   
(aa 1–138). All mutagenesis was performed using a QuikChange site- 
directed mutagenesis kit (Agilent Technologies), and the desired muta-
tions were confirmed by dideoxy DNA sequencing.
Cell culture and transfections
RAW264.7 cells purchased from the American Type Culture Collection 
were maintained in DME supplemented with 10% FBS. To induce dif-
ferentiation of RAW264.7 cells into osteoclasts, RAW264.7 cells were 
seeded on glass coverslips coated with collagen for 24 h and were then 
treated with GST-RANKL at 100 ng/ml for 7 d. The multinucleated cells 
with an enlarged cell morphology were considered osteoclasts. HUVECs 
were prepared as previously described (Jaffe et al., 1973) and were 
maintained in M199 supplemented with low serum growth supplements 
(Invitrogen). FAK
+/+ MEFs and FAK
/ MEFs were obtained from D. Ilic ´ 
and  were  maintained  as  previously  described  (Chen  et  al.,  2002).   
Inducible  Tet-FAK  cells  for  FAK  wt,  Y397F,  and  Y576F/Y577F  were   
obtained from S. Hanks (Vanderbilt University, Nashville, TN) and were 
maintained as previously described (Chang et al., 2005). To transform 
cells with v-Src, cells were transfected with pM–v-Src by Lipofectamine 
and selected by hygromycin. Lung adenocarcinoma CL1-5 cells were 
maintained as previously described (Chen and Chen, 2006). To knock-
down vimentin in CL1-5 cells, CL1-5 cells were transfected with 66.7 nM 
duplex siRNA specific to vimentin by Oligofectamine. 3 d later, the cells 
were harvested for analysis.
Lentiviral production and infection
The lentiviral expression system for shRNA was provided by the National 
RNAi Core Facility, Academia Sinica. For shRNA-mediated knockdown, 
the plasmids pLKO-AS1.puro encoding shRNAs were obtained from the 
National RNAi Core Facility, Academia Sinica. The target sequences for 
FAK are 5-CCGGTCGAATGATAAGGTGTA-3 (human #1), 5-GCCCAG-
GTTTACTGAACTTAA-3 (human #2), 5-GCCTTAACAATGCGTCAGTTT-3 
(mouse #1), and 5-CGAGTATTAAAGGTCTTTCAT-3 (mouse #2). The tar-
get sequences for PYK2 are 5-CAAGGCTCTCTCATCATCCAT-3 (human) 
and 5-GCCTGTCCTTTACACACTCAT-3 (mouse). The target sequence for   
p130Cas  is  5-CCTCAAGATTCTGGTTGGCAT-3  (mouse).  The  target  sequence   
for p190A is 5-CTAAGGCTAGAGGCACTATTA-3 (mouse). The target   
sequence for vimentin is 5-GCTTCAAGACTCGGTGGACTT-3 (mouse). 
For FAK expression, chicken FAK cDNA was amplified by a polymerase 
chain reaction and subcloned in frame to the NheI and AscI site of pLKO-AS2.
puro-FLAG vector. To produce lentiviruses, HEK293T cells were cotransfected 
with 2.25 µg pCMV-R8.91, 0.25 µg pMD.G, and 2.5 µg pLKO-AS1.
puro-shRNA (or pLKO-AS2.puro-FLAG-FAK) by Lipofectamine. After 3 d, 
the medium containing lentivirus particles was collected and stored at 80°C. 
The cells were infected with recombinant lentiviruses in the presence of   
reported to promote actomyosin-based cell contraction and sub-
sequent podosome dissolution (van Helden et al., 2008). There-
fore, it is likely that activation of the Rho–ROCK signaling 
pathway may facilitate disassembly of podosome rosettes. In this 
study, we observed that the rosettelike structure of podosomes 
always becomes aggregated before it is completely dissolved 
(Fig. 8 E). This aggregation of F-actin might be because of the 
increased Rho/ROCK activity and actomyosin-based contrac-
tion at podosome rosettes. Consistent with this notion, we found 
that the ROCK inhibitor Y27632 significantly delayed the dis-
assembly phase of podosome rosettes (Fig. 8 F). In osteoclasts, 
it has been shown that the formation of podosome belts is dis-
rupted when the Rho activity is high (Destaing et al., 2005).
The dynamics of intermediate filaments can be regulated 
by Rho signaling (Inada et al., 1999). In this study, we surprisingly 
found that the organization of vimentin filaments is regu-
lated by FAK in lung carcinoma CL1-5 cells (Fig. 9) and Src- 
transformed MEFs (Fig. S4). Depletion of FAK apparently   
enhances the organization of vimentin filaments in the cells, 
which is similar to the effect induced by active Rho. As FAK de-
pletion and Rho activation have an adverse effect on the forma-
tion of podosome rosettes, our data thus suggest that enhanced 
organization of vimentin filaments may be disadvantageous to 
podosome rosettes. Indeed, fewer or no vimentin filaments are 
present in the surrounding areas of podosome rosettes (Fig. 9 A). 
Partial depletion of vimentin rescues the defect in the formation 
of podosome rosettes caused by FAK depletion or Rho activa-
tion (Fig. 9, B and C). Moreover, we found that the S39A and 
S72A mutants of vimentin are less organized into filaments and   
less potent in suppressing podosome rosettes than the S39D   
and S72D mutants (Fig. 10). Thus, our results suggest that en-
hanced  phosphorylation  and  polymerization  of  vimentin  by 
ROCK antagonize the formation of podosome rosettes. A recent 
study by Schoumacher et al. (2010) described that vimentin fil-
aments penetrate invadopodia at a later stage of invadopodia 
maturation in carcinoma cells. However, it remains possible 
that the entry of vimentin filaments to invadopodia might be a 
mechanism for their disassembly.
In conclusion, we propose that although FAK is dispens-
able for the formation of dot-shaped podosomes/invadopodia, 
it is a key molecule necessary for the assembly of podosome 
rosettes. Tyrosine phosphorylation of p130Cas and suppres-
sion of Rho–ROCK signaling by FAK are important for the 
assembly. Finally, our results highlight that the infiltration of 
vimentin intermediate filaments may facilitate disassembly of 
podosome rosettes.
Materials and methods
Reagents
Polyclonal  anti-FAK  (A-17),  anti-Cdc42,  anticortactin  (H-191),  anti-Tks5 
(M300), and anti–MT1-MMP (L-15) antibodies, monoclonal anti–-tubulin 
(D-10) antibody, and duplex siRNA to vimentin were purchased from Santa 
Cruz Biotechnology, Inc. Monoclonal anti-FAK (clone 77), anti-p130Cas, 
anti-PYK2,  antipaxillin,  anti-p190RhoGAP,  antiphosphotyrosine  (PY20), 
anti-Rac1, and anti-RhoA antibodies and Matrigel were purchased from 
BD. Monoclonal antiacetylated tubulin (6-11B-1), anti-FLAG, antivinculin 
(clone hVIN-1), and antivimentin (clone V9 for immunofluorescent staining 
in human cells and clone VIM13.2 for immunofluorescent staining in mouse 
cells) antibodies, gelatin, nocodazole, and protein A–Sepharose beads JCB • VOLUME 195 • NUMBER 1 • 2011   128
(Axio Observer D1; Carl Zeiss) using a 63× Plan-Apochromat objective 
(NA 1.4 oil; Carl Zeiss). Images were captured every 2 min for 3 h using 
a digital camera (AxioCam MRm D; Carl Zeiss) and analyzed by Axio 
Vision Rel. software (version 4.8; Carl Zeiss). Wavelengths of 515–560 nm 
and 450–490 nm were used to excite mCherry and GFP. Beam path filters 
(beam paths 590–650 and 515–565 nm) were used to acquire images   
for the emission from mCherry and GFP.
Statistics
Statistical analyses were performed by Student’s t tests. Differences were 
considered to be statistically significant at P < 0.05.
Online supplemental material
Fig. S1 shows that podosome rosettes protrude from the ventral surface 
of cells. Fig. S2 shows that FAK is crucial for podosome rosette formation 
in Src-transformed NIH3T3 cells and CL1-5 lung carcinoma cells. Fig. S3 
shows that microtubules are not necessary for the formation of podosome 
rosettes in Src-transformed fibroblasts. Fig. S4 shows that FAK may promote 
podosome rosette formation by suppression of Rho signaling and vimentin 
filaments in Src-transformed MEFs. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201103016/DC1.
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